载脂蛋白a1抗体

载脂蛋白a1抗体Quantity size:

0.2ml

Concentration:

1mg/ml   Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

Apolipoprotein A I promotes cholesterol efflux from tissues to the liver for excretion. Apolipoprotein A I is the major protein component of high density lipoprotein (HDL) in the plasma.载脂蛋白a1抗体 Synthesized in the liver and small intestine, it consists of two identical chains of 77 amino acids; an 18 amino acid signal peptide is removed co-translationally and a 6 amino acid propeptide is cleaved post-translationally. Apolipoprotein A I is a cofactor for lecithin cholesterolacyltransferase (LCAT) which is responsible for the formation of most plasma cholesteryl esters. Defects in the Apolipoprotein A I gene are associated with HDL deficiency and Tangier disease.载脂蛋白a1抗体 The therapeutic potential of apoA-I has been recently assessed in patients with acute coronary syndromes, using a recombinant form of a naturally occurring variant of apoA-I. The availability of recombinant normal apoA-I should facilitate further investigation into the potential usefulness of apoA-I in preventing atherosclerotic vascular diseases.

载脂蛋白a1抗体Also known as:

AI BP; AIBP; ApoA I binding protein; Apolipoprotein A I; Apolipoprotein A 1; Apo AI; ApoA I; APOA1; APOA1/APOC3 fusion gene; Apo A1; Apo-A1; Apolipoprotein A I precursor; Apolipoprotein A I binding protein; Apolipoprotein AI; Apolipoprotein of high density lipoprotein; ApolipoproteinAI; Brp14; Ltw1; Lvtw1; MGC117399; MGC119143; MGC119144; MGC119145; NAD(P)H hydrate epimerase; NAD(P)HX epimerase; YjeF N terminal domain containing protein 1; yjeF_N1; YJEFN1; APOA1_HUMAN; Sep1; Sep2.

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, .

●

Immunogen: KLH conjugated synthetic peptide derived from human Apolipoprotein A 1.

●

载脂蛋白a1抗体Predicted Molecular Weight: 28kDa.

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  ICC=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl135Po01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)

kl135Ra01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)

kl139Ca01肿瘤坏死因子相关凋亡诱导配体(TRAIL)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)

kl139Hu01肿瘤坏死因子相关凋亡诱导配体(TRAIL)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)

kl139Mu01肿瘤坏死因子相关凋亡诱导配体(TRAIL)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)

kl139Ra01肿瘤坏死因子相关凋亡诱导配体(TRAIL)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)

kl140Bo01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)

kl140Ga01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)

kl140Hu01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)

kl140Mu01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)

kl140Po01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)

kl140Ra01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)

kl140Rb51尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)

kl141Bo01尿激酶型纤溶酶原激活因子受体(ukl)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (ukl)

kl141Hu01尿激酶型纤溶酶原激活因子受体(ukl)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (ukl)

kl141Mu01尿激酶型纤溶酶原激活因子受体(ukl)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (ukl)

kl141Ra01尿激酶型纤溶酶原激活因子受体(ukl)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (ukl)

kl141Si01尿激酶型纤溶酶原激活因子受体(ukl)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (ukl)